Long-acting veterinary polypeptides and methods of producing and administering same
OwnerFuad Fares, Udi Fimainventors
Life of this patent
Estimating the term…
Abstract
A polypeptide and polynucleotides comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a non-human peptide-of-interest are disclosed. Pharmaceutical compositions comprising the non-human polypeptides and polynucleotides of the invention and methods of using both human and non-human polypeptides and polynucleotides are also disclosed.
Claims33
A polypeptide comprising a non-human peptide of interest and at least two chorionic gonadotrophin carboxy terminal peptides, wherein a first chorionic gonadotrophin carboxy terminal peptide of said at least two chorionic gonadotrophin carboxy terminal peptides is attached to an amino terminus of said non-human peptide of interest, and a second chorionic gonadotrophin carboxy terminal peptide of said at least two chorionic gonadotrophin carboxy terminal peptides is attached to a carboxy terminus of said non-human peptide of interest.
A polynucleotide comprising a coding portion encoding a polypeptide, said polypeptide comprising a non-human peptide of interest and at least two chorionic gonadotrophin carboxy terminal peptides, wherein a first chorionic gonadotrophin carboxy terminal peptide of said at least two chorionic gonadotrophin carboxy terminal peptides is attached to an amino terminus of said non-human peptide of interest, and a second chorionic gonadotrophin carboxy terminal peptide of said at least two chorionic gonadotrophin carboxy terminal peptides is attached to the carboxy terminus of said non-human peptide of interest.
A cell comprising the expression vector of claim 22.
A method of treating or reducing the incidence associated with a growth, weight-related, or metabolic condition in a non-human subject, said method comprising administering to said subject a therapeutically effective amount of a polypeptide, said polypeptide comprising:
- (a) a peptide of interest and (b) at least two chorionic gonadotrophin carboxy terminal peptides, wherein:
- a first chorionic gonadotrophin carboxy terminal peptide of said at least two chorionic gonadotrophin carboxy terminal peptides is attached to an amino terminus of said peptide of interest, and a second chorionic gonadotrophin carboxy terminal peptide of said at least two chorionic gonadotrophin carboxy terminal peptides is attached to the carboxy terminus of said peptide of interest,
- thereby treating said non-human subject having a growth, weight-related, or metabolic condition.
A method of administering a peptide of interest to a non-human subject in need thereof, comprising the step of attaching a first chorionic gonadotrophin carboxy terminal peptide to an amino terminus of said peptide of interest and a second chorionic gonadotrophin carboxy terminal peptide to the carboxy terminus of said peptide of interest, thereby generating an improved polypeptide for administration to said subject, thereby administering a peptide of interest to a subject in need thereof.
Dependencies are inferred from the claim text.